Facebook
Twitter
LinkedIn
Forward
Course DescriptionKaitlin Morrison, PhD takes you through when a correlative assay is considered an FDA regulated device and what types of devices requi
|
Ashley Weiner, MD, PhD, presents on the role of radiotherapy for small-cell lung cancer. She provides overview of radiation oncology, and a walk through a patient's pathway from initial consultation with a radiation oncologist to treatment and follow-up. Finally, she reviews the indications for, logistics of, and side effects of radiation for the treatment of small cell lung cancer (limited and extensive stage).
|
Joe Polich, MSW, LCSWA, JD will provide a foundational knowledge to providers who come in contact with patients with cancer who are also experiencing IPV. Beginning with a quick introduction to some basic concepts of the dynamics of IPV in general, we will discuss the intersection of the provision of care to a patient with cancer and the dynamics involved in IPV.
|
Tracy Vernon-Platt, DNP, ANP-BC, will provide a systematic approach to EKG interpretation. It will also discuss common arrhythmias in patients with cancer, identification of the arrhythmias, and management strategies.
|
Tammy Triglianos, DNP, ANP-BC, AOCNP, and Mary Dunn, MSN, RN, OCN, NP-C, will highlight the multifaceted challenges faced by cancer survivors and emphasize the importance of personalized care. By examining the physical, emotional, and social needs that evolve over time, they will discuss strategies for approaches to care, including interdisciplinary collaboration, to improve quality of life.
|
Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.
|
Lauren Lux, MSW and Melissa Matson, MSN, RN, AGPCNP-BC and Catharine Swift, MSW, LCSW highlight tools and strategies that healthcare providers can deploy to meet the medical and psychosocial needs of the AYAs in their care.
|
Mark Woodcock gives a broad overview of the multidisciplinary approaches for the treatment of soft tissue sarcomas in adults, and detailed updates in management with systemic therapies. Specific attention is paid to sarcoma sub-types which may warrant special considerations.
|
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will go into more detail for treatment options and considerations for treating localized prostate cancer and the management of side effects.
|
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will provide a general overview of Prostate Cancer. The audience will learn about basic pathophysiology and epidemiology as it relates to both local and advanced disease. This course will then provide insight into the pros & cons of prostate cancer screening as well as the accepted diagnostic procedures & scoring.
|